MCID: KMR001
MIFTS: 50

Kimura Disease malady

Categories: Rare diseases, Bone diseases, Skin diseases, Immune diseases

Aliases & Classifications for Kimura Disease

About this section
Sources:
11Disease Ontology, 13DISEASES, 31ICD10 via Orphanet, 39MeSH, 40MESH via Orphanet, 45NCIt, 48NIH Rare Diseases, 50Novoseek, 54Orphanet, 62SNOMED-CT, 68UMLS, 69UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Kimura Disease:

Name: Kimura Disease 11 48 54 50 13 68
Angiolymphoid Hyperplasia with Eosinophilia 48
Eosinophilic Hyperplastic Lymphogranuloma 48
Eosinophilic Lymphofollicular Granuloma 48
 
Eosinophilic Granuloma of Soft Tissue 48
Eosinophilic Lymphofolliculosis 48
Eosinophilic Lymphogranuloma 54
Kimura's Disease 11

Characteristics:

Orphanet epidemiological data:

54
kimura disease:
Prevalence: <1/1000000 (Worldwide); Age of onset: Adult; Age of death: normal life expectancy

Classifications:



External Ids:

Disease Ontology11 DOID:7365
MeSH39 D000796
NCIt45 C26867
Orphanet54 ORPHA482
UMLS via Orphanet69 C0033838
MESH via Orphanet40 D000796
ICD10 via Orphanet31 I89.8

Summaries for Kimura Disease

About this section
NIH Rare Diseases:48 Kimura disease is a rare, benign, chronic disorder that causes inflammation of tissue (nodules) under the skin of the head or neck.  these nodules tend to recur despite treatment. the cause of this condition is unknown, but may be due to an immune response. last updated: 1/20/2011

MalaCards based summary: Kimura Disease, also known as angiolymphoid hyperplasia with eosinophilia, is related to histiocytoid hemangioma and skin epithelioid hemangioma, and has symptoms including Array, Array and Array. An important gene associated with Kimura Disease is RNASE3 (Ribonuclease A Family Member 3), and among its related pathways are OX40 Pathway and IL-9 Signaling Pathways and their Primary Biological Effects in Different Immune Cell Types. Affiliated tissues include skin, lymph node and bone, and related mouse phenotypes are hematopoietic system and immune system.

Related Diseases for Kimura Disease

About this section

Diseases related to Kimura Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 121)
idRelated DiseaseScoreTop Affiliating Genes
1histiocytoid hemangioma11.5
2skin epithelioid hemangioma11.2
3hemangioma10.3
4restrictive cardiomyopathy10.3IL5, RNASE3
5renal hypertension10.2IL5, RNASE3
6brown shrimp allergy10.2IL5, RNASE3
7papillary squamous carcinoma10.2IL4, IL5
8hypersensitivity vasculitis10.2IL4, IL5
9benign meningioma10.2IL5, RNASE3
10peptidic growth factors deficiency10.2CCL11, IL5
11allescheriosis10.2IL4, IL5
12urethral intrinsic sphincter deficiency10.2IL4, IL5
13bone peripheral neuroepithelioma10.2IL4, IL5
14indian plum allergy10.2IL4, IL5
15natural killer cell leukemia10.2CCL11, IL5
16lactose intolerance10.2IL4, IL5
17askin's tumor10.2IL4, IL5
18spastic diplegia10.2CCL11, IL5
19breast intracanalicular fibroadenoma10.2IL4, IL5
20histoplasmosis retinitis10.2IL4, IL5
21metal allergy10.2IL5, RNASE3
22hypercementosis10.2CCL5, IL5
23psychotic disorder10.2CCL11, IL4
24bile duct signet ring cell carcinoma10.2IL5, RNASE3
25isolated klippel-feil syndrome10.2IL4, IL5
26retinal vascular disease10.2CCL11, IL4
27small intestine lymphoma10.2IL5, RNASE3
28dissociated nystagmus10.2IL4, IL5
29vulvar disease10.2CCL5, RNASE3
30isthmus cancer10.2CCL11, IL4
31duodenal somatostatinoma10.2IL4, IL5
32coenurosis10.2IL4, IL5
33smooth muscle tumor10.2CCL5, IL5
34astrocytoma10.2IL5, RNASE3
35hidradenitis suppurativa10.1CCL11, CCL5
36central nervous system origin vertigo10.1IL4, RNASE3
37leukoplakia of penis10.1CCL5, IL4
38marasmus10.1IL4, IL5, RNASE3
39lens-induced iridocyclitis10.1IL4, IL5, RNASE3
40abnormal retinal correspondence10.1IL4, IL5
41spastic paraplegia 3a, autosomal dominant10.1IL4, IL5, RNASE3
42multiple epiphyseal dysplasia due to collagen 9 anomaly10.1IL4, IL5, RNASE3
43luminal breast carcinoma10.1IL4, IL5, RNASE3
44wilkes stevenson syndrome10.1IL5, RNASE3
45acute gonococcal prostatitis10.1IL4, IL5, RNASE3
46orbit alveolar rhabdomyosarcoma10.1IL4, IL5, RNASE3
47actinic keratosis10.1IL4, IL5, RNASE3
48paratyphoid fever10.1IL4, IL5, RNASE3
49uterus interstitial leiomyoma10.1IL4, IL5, RNASE3
50necrotizing gastritis10.1CCL11, IL5, RNASE3

Graphical network of the top 20 diseases related to Kimura Disease:



Diseases related to kimura disease

Symptoms & Phenotypes for Kimura Disease

About this section

Human phenotypes related to Kimura Disease:

 54 64
id Description HPO Frequency Orphanet Frequency HPO Source Accession
1 eosinophilia64 54 Very frequent (99-80%) HP:0001880
2 follicular hyperplasia64 54 Very frequent (99-80%) HP:0002729
3 increased ige level64 54 Very frequent (99-80%) HP:0003212
4 lymphadenopathy54 Frequent (79-30%)
5 abnormality of the salivary glands64 54 Occasional (29-5%) HP:0010286

MGI Mouse Phenotypes related to Kimura Disease according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053977.5CCL11, CCL5, CCR3, IL33, IL4, IL5
2MP:00053877.5CCL11, CCL5, CCR3, IL33, IL4, IL5
3MP:00053887.3CCL11, CCR3, IL33, IL4, IL5, TSLP

Drugs & Therapeutics for Kimura Disease

About this section

Drugs for Kimura Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 155)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Carvedilolapproved, investigationalPhase 416872956-09-32585
Synonyms:
(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol
(+-)-1-(Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol
(+-)-1-Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol
(+/-)-1-(Carbazol-4-yloxy)-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol
1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol
1-(9H-carbazol-4-yloxy)-3-[(2-{[2-(methyloxy)phenyl]oxy}ethyl)amino]propan-2-ol
1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol
1-(9H-carbazol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol
107741-96-8
72956-09-3
AB1004830
AC-1641
AC1L1E0B
Artist
Artist (TN)
Atlana Pharma brand of carvedilol
BM 14190
BM-14-190
BM-14.190
BM-14190
BRD-A10977446-001-04-8
BRD-A10977446-045-01-1
Bio-0014
C043211
C06875
C2260
C24H26N2O4
CHEBI:3441
CHEMBL723
CID2585
CPD000449280
Carvedilol
Carvedilol (JAN/USAN/INN)
Carvedilol [USAN:INN:BAN:JAN]
Carvedilolum
Carvedilolum [Latin]
Coreg
Coreg (TN)
Coreg CR
Coropres
Coropress
D00255
DB01136
DQ 2466
DQ-2466
Dibloc
 
Dilatrend
EG-P042
Eucardic
GlaxoSmithKline brand of carvedilol
HMS2051N03
HMS2089B09
HMS2093E12
HSDB 7044
I06-0064
I06-1477
KBio2_002145
KBio2_004713
KBio2_007281
KBio3_002323
KBioGR_001252
KBioSS_002145
Kredex
L001243
LS-121875
Lakeside brand of carvedilol
MLS000758299
MLS000759508
MLS001424092
MolPort-003-666-814
NCGC00167832-01
NCGC00167832-02
NCGC00167832-03
Querto
Roche brand of carvedilol
SAM001246736
SAM001247021
SK&F-105517
SKF 105517
SMR000449280
SPBio_001885
STK621453
Spectrum2_001673
Spectrum3_001182
Spectrum4_000636
Spectrum5_001436
Spectrum_001665
TL8005080
UNII-0K47UL67F2
carvedilol
carvedilol, (+-)-isomer
carvedilol, (R)-isomer
carvedilol, (S)-isomer
carvedilol, 14C-labeled
2
PitavastatinapprovedPhase 466147511-69-1, 147526-32-76366718, 5282452
Synonyms:
( )-(3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoic acid
(3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid
(3R,5S,6E)-7-(2-Cyclopropyl-4-(p-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoic acid
(3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate
(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid
111GE002
147511-69-1
147526-32-7
2C25H23FNO4.Ca
AC1NR03G
AC1NR03J
AKOS005145916
Alipza
Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate), monocalcium salt
C13334
CCRIS 8652
CID5282451
CID5282452
D01862
Itavastatin
Itavastatin calcium
KS-1220
LS-190698
 
LS-74594
LS-74595
Livalo
Livalo (TN)
Livalo, Pitavastatin calcium
Livazo
MolPort-006-822-984
NK 104
NK-104
NKS-104
Nisvastatin
P 872441
P-872441
Pitavastatia
Pitavastatin
Pitavastatin [INN]
Pitavastatin calcium
Pitavastatin calcium (JAN)
Pitavastatin hemicalcium
Pitavastatine
Pitavastatinum
S1759_Selleck
ZINC01534965
calcium (E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate
3
TiclopidineapprovedPhase 447155142-85-35472
Synonyms:
5-((2-Chlorophenyl)methyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridine
5-(2-Chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine
5-[(2-chlorophenyl)methyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridine
5-[(2-chlorophenyl)methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine
55142-85-3
AC-15204
AC1L1KFB
BIDD:PXR0169
BPBio1_000191
BRD-K00603606-003-03-4
BRN 1216802
BSPBio_000173
C07140
C14H14ClNS
CAS-53885-35-1
CHEBI:9588
CHEMBL833
CID5472
D08594
DB00208
EINECS 259-498-5
HMS2089I18
L001108
LS-152434
MLS001201825
MolPort-002-507-849
 
NCGC00016872-01
NCGC00016872-02
NCGC00024361-04
PCR 5332
Prestwick0_000047
Prestwick1_000047
Prestwick2_000047
Prestwick3_000047
SMR000641861
SPBio_002094
STK589340
STOCK5S-54105
Ticlid
Ticlopidin-Puren
Ticlopidin-Puren (TN)
Ticlopidina
Ticlopidina [INN-Spanish]
Ticlopidine (INN)
Ticlopidine HCL
Ticlopidine Hydrochloride
Ticlopidine [INN:BAN]
Ticlopidinum
Ticlopidinum [INN-Latin]
UNII-OM90ZUW7M1
UNM-0000345023
ZINC19594599
ticlopidine
4
Aspirinapproved, vet_approvedPhase 4115250-78-22244
Synonyms:
11126-35-5
11126-37-7
1oxr
2-(Acetyloxy)benzoate
2-(Acetyloxy)benzoic acid
2-Acetoxybenzenecarboxylic acid
2-Acetoxybenzoate
2-Acetoxybenzoic acid
2-Carboxyphenyl acetate
2349-94-2
26914-13-6
50-78-2
8-hour Bayer
98201-60-6
A 5376
A.S.A
A.S.A.
A.S.A. Empirin
A.S.A. empirin
A2093_SIGMA
A3160_SIGMA
A5376_SIGMA
A6810_SIGMA
AB1003266
AC 5230
AC1L1D8U
AC1Q1LA0
ACETYLSALICYLIC ACID
AI3-02956
AIN
AKOS000118884
ASA
Acenterine
Acesal
Acetal
Acetard
Aceticyl
Acetilsalicilico
Acetilum acidulatum
Acetisal
Acetol
Acetonyl
Acetophen
Acetosal
Acetosalic acid
Acetosalin
Acetoxybenzoic acid
Acetylin
Acetylsal
Acetylsalicylate
Acetylsalicylic acid
Acetylsalicylsaeure
Acetylsalicylsaure
Acetylsalicylsäure
Acetylsalycilic acid
Acetyonyl
Acetysal
Acetysalicylic acid
Acide acetylsalicylique
Acido O-acetil-benzoico
Acido acetilsalicilico
Acidum acetylsalicylicum
Acimetten
Acisal
Acylpyrin
Adiro
Aloxiprimum
Asacard
Asagran
Asatard
Ascoden-30
Aspalon
Aspec
Aspergum
Aspir-Mox
Aspirdrops
Aspirin
Aspirin (JP15/USP)
Aspirin [BAN:JAN]
Aspirina 03
Aspirine
Asprin
Aspro
Aspro Clear
Asteric
Azetylsalizylsaeure
Azetylsalizylsäure
BIDD:GT0118
BRN 0779271
Bay-e-4465
Bayer
Bayer Aspirin 8 Hour
Bayer Buffered
Bayer Extra Strength Aspirin For Migraine Pain
Bayer Plus
Benaspir
Bi-prin
Bialpirina
Bialpirinia
Bufferin
C01405
CCRIS 3243
CHEBI:15365
CHEMBL25
CID2244
Caprin
Cardioaspirin
Cardioaspirina
Cemirit
Claradin
Clariprin
Colfarit
Contrheuma retard
Coricidin
Crystar
D00109
D001241
DB00945
Decaten
Delgesic
Dispril
DivK1c_000555
Dolean pH 8
Duramax
ECM
EINECS 200-064-1
EU-0100038
Easprin
Easprin (TN)
Ecolen
Ecotrin
Empirin
Empirin with Codeine
Endosprin
Endydol
Entericin
Enterophen
 
Enterosarein
Enterosarine
Entrophen
Extren
Globentyl
Globoid
HMS1920E13
HMS2090G03
HMS2091K13
HMS501L17
HSDB 652
Helicon
I14-7505
IDI1_000555
Idragin
Istopirin
KBio1_000555
KBio2_001725
KBio2_002271
KBio2_004293
KBio2_004839
KBio2_006861
KBio2_007407
KBio3_002149
KBio3_002751
KBioGR_000398
KBioGR_002271
KBioSS_001725
KBioSS_002272
Kapsazal
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
LS-143
Levius
Lopac-A-5376
Lopac0_000038
MLS001055329
MLS001066332
MLS001336045
MLS001336046
Magnecyl
Measurin
Medisyl
Micristin
MolPort-000-871-622
NCGC00015067-01
NCGC00015067-04
NCGC00015067-09
NCGC00090977-01
NCGC00090977-02
NCGC00090977-03
NCGC00090977-04
NCGC00090977-05
NCGC00090977-06
NCGC00090977-07
NCI60_002222
NINDS_000555
NSC 27223
NSC27223
NSC406186
Neuronika
Novid
Nu-seals
Nu-seals aspirin
O-(Acetyloxy)benzoate
O-(Acetyloxy)benzoic acid
O-Acetoxybenzoate
O-Acetoxybenzoic acid
O-Acetylsalicylic acid
O-Carboxyphenyl acetate
O-accetylsalicylic acid
O-acetylsalicylic acid
PL-2200
Persistin
Pharmacin
Pirseal
Polopirin
Polopiryna
Premaspin
R16CO5Y76E [UNII]
Rheumin tabletten
Rheumintabletten
Rhodine
Rhonal
Ronal
S-211
SMR000059138
SP 189
SPBio_001838
SPECTRUM1500130
ST075414
Salacetin
Salcetogen
Saletin
Salicylic acid acetate
Salicylic acid, acetate
Salospir
Solfrin
Solprin
Solprin acid
Solpyron
Solupsan
Spectrum2_001899
Spectrum3_001295
Spectrum4_000099
Spectrum5_000740
Spectrum_001245
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
Supac
Tasprin
Temperal
Toldex
Triaminicin
Triple-sal
UNII R16CO5Y76E
UNII-R16CO5Y76E
UNII=R16CO5Y76E
UNM-0000306102
Vanquish
WLN: QVR BOV1
XAXA
Xaxa
Yasta
ZORprin
acide 2-(acétyloxy)benzoïque
acide acétylsalicylique
aspirin
cMAP_000006
component of Midol
component of Synirin
nchem.859-comp6
o-Acetoxybenzoic acid
o-Carboxyphenyl acetate
o-acetoxybenzoic acid
o-carboxyphenyl acetate
salicylic acid acetate
ácido acetilsalicílico
5
EverolimusapprovedPhase 41940159351-69-66442177
Synonyms:
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy
07741_FLUKA
159351-69-6
40-O-(2-hydroxyethyl)-rapamycin
42-O-(2-Hydroxyethyl)rapamycin
Afinitor
CERTICAN(R)
CHEMBL1201755
Certican
D02714
DB01590
 
Everolimus
Everolimus (JAN/USAN/INN)
Everolimus [USAN]
LS-143292
MolPort-003-847-342
MolPort-003-925-588
NCGC00167512-01
NVP-RAD-001
RAD 001
RAD-001
RAD-001C
RAD001
RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus
S1120_Selleck
SDZ-RAD
UNII-9HW64Q8G6G
Zortress
everolimus
6
Sirolimusapproved, investigationalPhase 4194053123-88-95284616, 6436030, 46835353
Synonyms:
(-)-Rapamycin
(-)-rapamycin
1fkb
1pbk
23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine
23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine
23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29
3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
53123-88-9
A422989, NSC226080
AC-722
AC1L1JH9
AC1L7MJ9
AC1L9ZMV
AY 22989
AY-22989
AY22989
Ambotz53123-88-9
Antibiotic AY 22989
BIDD:PXR0165
Bio1_000293
Bio1_000782
Bio1_001271
Bio2_000375
Bio2_000855
BiomolKI2_000084
C07909
C51H79NO13
CBiol_002007
CCRIS 9024
CHEBI:100923
CHEBI:9168
CHEMBL413
CID10213190
CID10795871
CID11949238
CID11959112
CID313006
CID478951
CID5040
CID5284616
CID5358081
CID5374464
CID5460439
CID5497196
CID5924240
CID6436030
CID6610270
CID6610346
CID6711160
CID6713081
CID9833581
CID9854379
CID9854380
CID9962926
CID9962928
D00753
DB00877
DE-109
DivK1c_006936
 
FT-0082351
HMS2089A21
HSDB 7284
KBio1_001880
KBio2_000410
KBio2_002978
KBio2_005546
KBio3_000779
KBio3_000780
KBioGR_000410
KBioSS_000410
LCP-Siro
LMPK06000003
LS-143290
MLS000028373
MS-R001
MolMap_000043
MolPort-003-959-433
NCGC00021305-05
NCI60_001851
NCIMech_000355
NSC 226080
NSC226080
Perceiva
QTL1_000069
R0395_SIAL
R0395_SIGMA
RAP
RAPA
RPM
Rapammune
Rapamune
Rapamune (TN)
Rapamycin
Rapamycin (TN)
Rapamycin C-7, analog 4
Rapamycin Immunosuppressant Drug
Rapamycin from Streptomyces hygroscopicus
S1039_Selleck
SIIA 9268A
SILA 9268A
SILA9268A
SMP1_000255
SMR000058564
Sirolimus
Sirolimus (RAPAMUNE)
Sirolimus (USAN/INN)
Sirolimus [USAN:BAN:INN]
Sirolimus, Rapamune,Rapamycin
SpecPlus_000840
UNII-W36ZG6FT64
UNM-0000358684
WY-090217
Wy 090217
heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy
nchembio.100-comp4
nchembio.2007.42-comp2
nchembio.79-comp1
nchembio762-comp1
nchembio883-comp3
rapamycin
sirolimus
7
Miconazoleapproved, investigational, vet_approvedPhase 4370622916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Micantin (nitrate)
Miconasil Nitrate
 
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
8
Pregabalinapproved, illicit, investigationalPhase 4, Phase 3361148553-50-85486971
Synonyms:
(3S)-3-(aminomethyl)-5-methylhexanoic acid
(R-)-3-isobutyl GABA
(S)-3-(Aminomethyl)-5-methylhexanoic acid
(S)-3-Isobutyl gaba
(S+)-3-isobutyl GABA
121GE001
148553-50-8
3-Isobutyl gaba
3-isobutyl GABA
AC-1158
AC1NUP03
AKOS005145504
C080245
C8H17NO2
CHEBI:236161
CHEMBL1059
CI 1008
CI-1008
CID5486971
 
D02716
DB00230
FT-0080911
HSDB 7530
LS-75191
Lyrica
Lyrica (TN)
MolPort-000-861-733
PD 144723
PD-144723
Pregabalin
Pregabalin (JAN/USAN/INN)
Pregabalin [USAN]
Pregablin
S-(+)-3-isobutylgaba
S1731_Selleck
SBB062901
TL8001062
TOS-BB-0910
UNII-55JG375S6M
9
Valsartanapproved, investigationalPhase 4295137862-53-460846
Synonyms:
(2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
(S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine
(S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine
(s)-2-(n-((2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoic acid
137862-53-4
AC-4543
AC1L1U1M
AC1Q5QIK
Ambap137862-53-4
Aventis brand of valsartan
BIDD:GT0345
BRD-K45158365-001-02-3
BSPBio_003501
Bio-0796
C081489
C24H29N5O3
CEPA brand of valsartan
CGP 48933
CGP-48933
CHEBI:9927
CHEMBL1069
CID60846
CPD000466318
D00400
DB00177
Diovan
Diovan (TN)
Diovan, Valsartan
Esteve brand of valsartan
HMS1922L21
HMS2051L12
HMS2093K22
HSDB 7519
KBio2_002287
KBio2_004855
KBio2_007423
KBio3_003006
KBioGR_001078
KBioSS_002289
 
Kalpress
L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI)
LS-161334
Lacer brand of valsartan
MLS000759423
MLS001424088
Miten
MolPort-002-507-854
MolPort-003-666-608
N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine
N-(P-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine
N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine
N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valine
N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine
N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine
Nisis
Nisis||
Novartis brand of valsartan
Provas
S1894_Selleck
SAM001246581
SMR000466318
SPBio_001260
SPECTRUM1505209
Sanol brand of valsartan
Schwarz brand of valsartan
Spectrum2_001120
Spectrum3_001831
Spectrum4_000749
Spectrum5_001582
Spectrum_001796
TL8000869
Tareg
UNII-80M03YXJ7I
Vals
Valsarran
Valsartan (JAN/USAN/INN)
Valsartan [USAN:INN]
valsartan
walsartan
|Tareg
10
RivaroxabanapprovedPhase 4259366789-02-8
Synonyms:
 
Xarelto
bay 59-7939
11EdoxabanapprovedPhase 461480449-70-5
12
WarfarinapprovedPhase 447081-81-26691, 54678486
Synonyms:
(-)-Warfarin
(S)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone
(S)-Warfarin
(phenyl-1 acetyl-2 ethyl) 3-hydroxy-4 coumarin
(phenyl-1 acetyl-2 ethyl) 3-hydroxy-4 coumarine
1-(4'-Hydroxy-3'-coumarinyl)-1-phenyl-3-butanone
200 Coumarin
200 coumarin
3-(1'-Phenyl-2'-acetylethyl)-4-hydroxycoumarin
3-(Acetonylbenzyl)-4-hydroxycoumarin
3-(alpha-Acetonylbenzyl)-4-hydroxycoumarin
3-(alpha-Phenyl-beta-acetylaethyl)-4-hydroxycumarin
3-(alpha-Phenyl-beta-acetylethyl)-4-hydroxycoumarin
4-Hydroxy-3- (3-oxo-1-fenyl-butyl) cumarine
4-Hydroxy-3- (3-oxo-1-phenyl-butyl)-cumarin
4-Hydroxy-3-(3-oxo-1-fenyl-butyl) cumarine
4-Hydroxy-3-(3-oxo-1-phenyl-butyl)-cumarin
4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one
4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one
4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin
4-Idrossi-3- (3-oxo-)-fenil-butil)-cumarine
4-Idrossi-3-(3-oxo-)-fenil-butil)-cumarine
4-Idrossi-3-(3-oxo-1-fenil-butil)-cumarine
45706_FLUKA
45706_RIEDEL
4oh-coumarin deriv.
5543-56-6
5543-57-7
81-81-2
A2250_FLUKA
A2250_SIGMA
AC-15978
AC1L1N37
AC1Q6AN3
AR-1E2310
Arab Rat Death
Arab rat death
Arab rat deth
Athrombin
Athrombin-K
Athrombin-k
Athrombine-K
Athrombine-k
BRD-A24514565-001-02-2
BRD-A24514565-236-01-6
BRN 1293536
BSPBio_002026
Bio-0586
Brumolin
C01541
C19H16O4
CBDivE_002127
CBDivE_013236
CBKinase1_000192
CBKinase1_012592
CHEBI:10033
CHEMBL1464
CID6691
CO-Rax
Caswell No. 903
Choice
Choice (TN)
Co-Rax
Co-rax
Compound 42
Coumadin
Coumadin Tabs
Coumafen
Coumafene
Coumafene [French]
Coumaphen
Coumaphene
Coumarins
Coumefene
Cov-R-Tox
Cov-R-tox
D-Con
D08682
DB00682
DL-3-(alpha-acetonylbenzyl)-4-hydroxycoumarin
Dethmor
Dethnel
Dicusat E
Dicusat e
DivK1c_000444
EINECS 201-377-6
EINECS 226-907-3
EPA Pesticide Chemical Code 086002
Eastern states duocide
Fasco fascrat powder
Frass-Ratron
Frass-ratron
HMS1921K07
HMS2092C20
HMS501G06
HSDB 1786
I14-0958
IDI1_000444
Jantoven
KBio1_000444
KBio2_000674
KBio2_003242
KBio2_005810
KBio3_001526
KBioGR_000901
KBioSS_000674
Killgerm sewarin p
Kumader
Kumadu
Kumatox
Kypfarin
LS-55083
Latka 42
Latka 42 [Czech]
Liqua-tox
MLS001304042
Maag Rattentod Cum
Maag rattentod cum
Mar-Frin
Mar-frin
Marevan
Martin'S mar-frin
Martin's mar-frin
 
Maveran
MolPort-001-787-822
Mouse pak
NCGC00094810-01
NCGC00094810-02
NCGC00159398-03
NCGC00178855-01
NINDS_000444
NSC 59813
NSC59813
PS104_SUPELCO
Panwarfin
Place-Pax
Place-pax
Prothromadin
RAX
RCR grey squirrel killer concentrate
RCRA waste no. P001
Rat & mice bait
Rat and mice bait
Rat-B-gon
Rat-Gard
Rat-Kill
Rat-Mix
Rat-O-cide #2
Rat-O-cide no. 2
Rat-Ola
Rat-Trol
Rat-a-way
Rat-alpha-way
Rat-b-gon
Rat-beta-gon
Rat-gard
Rat-kill
Rat-mix
Rat-o-cide #2
Rat-ola
Rat-trol
Ratorex
Ratox
Ratoxin
Ratron
Ratron G
Ratron g
Rats-no-more
Ratten-Koederrohr
Ratten-koederrohr
Rattenstreupulver Neu Schacht
Rattenstreupulver neu schacht
Rattenstreupulver new schacht
Rattentraenke
Rattunal
Rcra waste number P001
Ro-Deth
Ro-deth
Rodafarin
Rodafarin C
Rodafarin c
Rodex
Rodex blox
Rosex
Rough & ready mouse mix
Rough and ready mouse mix
SMP1_000316
SMR000718754
SPBio_000870
SPECTRUM1500613
STK364490
Sakarat
Sewarin
Sofarin
Solfarin
Sorexa Plus
Sorexa plus
Spectrum2_000935
Spectrum3_000583
Spectrum4_000381
Spectrum5_001751
Spectrum_000194
Spray-trol brand roden-trol
Temus W
Temus w
Tintorane
Tox-Hid
Tox-hid
Twin light rat away
UNII-5Q7ZVV76EI
Vampirinip II
Vampirinip III
Vampirinip iii
W.A.R.F. 42
WARF compound 42
WLN: T66 BOVJ DYR&1V1 EQ
Waran
Warf 10
Warf 42
Warfarat
Warfarin (INN)
Warfarin (and salts of)
Warfarin Plus
Warfarin Q
Warfarin [BSI:ISO]
Warfarin [INN:BAN]
Warfarin plus
Warfarin plus [discontinued]
Warfarin sodium
Warfarin titrated to an INR of 2.5-3.0
Warfarin(R)
Warfarina
Warfarina [INN-Spanish]
Warfarine
Warfarine [INN-French]
Warfarine [ISO-French]
Warfarinum
Warfarinum [INN-Latin]
Warficide
Warfilone
Zoocoumarin
Zoocoumarin [Netherlands and USSR]
Zoocoumarin [Russian]
delta-Con
nchembio.307-comp19
rac-Warfarin
warfarin
13
ApixabanapprovedPhase 4154503612-47-310182969
Synonyms:
1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahyd
2p16
503612-47-3
AKOS005146204
Apixaban
Apixaban (JAN/USAN/INN)
BMS 562247-01
BMS-562247
BMS-562247-01
BMS-562247-01, Apixaban
 
CHEBI:49620
CHEMBL231779
CID10182969
D03213
DB07828
GG2
S1593_Selleck
UNII-3Z9Y7UWC1J
apixabanum
apixabán
ro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid amide
14
LosartanapprovedPhase 4286114798-26-43961
Synonyms:
(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol
(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-5-yl)methanol
(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol
114798-26-4
124750-99-8 (mono-potassium salt)
1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI)
2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol
2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl-1H-imidazole-5-methanol
2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole
2-butyl-4-chloro-1-[p-(o-1H-tetrazol-5ylphenyl)benzyl]imidazole-5-methanol
2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole
2-n-butyl-4-chloro-5-hydroxymethyl-1-[[2'-(1H-tetrazol-5-yl)-biphenyl-4-yl]methyl]imidazole
AC1L1H3Q
BIDD:GT0286
BRD-K76205745-001-02-5
BSPBio_002695
C07072
C22H23ClN6O
CHEBI:6541
CHEMBL191
CID3961
CL23623
Cozaar
D08146
DB00678
DUP 89
DuP 89
DuP-753
HMS1922J13
HMS2093E22
Hyzaar
I14-9710
Jsp001094
KBio2_002193
 
KBio2_004761
KBio2_007329
KBio3_001915
KBioGR_001611
KBioSS_002193
L000351
LOSARTAN POTASSIUM
LS-78746
Lacidipine
Lortaan
Losartan
Losartan (INN)
Losartan Potassium
Losartan [INN:BAN]
Losartan monopotassium salt
Losartic
Losartic (TN)
MK-954
MK954
MolPort-003-666-553
NCGC00095125-01
NCGC00095125-02
NCGC00095125-03
Oprea1_644635
SPBio_001893
SPECTRUM1504268
Spectrum2_001677
Spectrum3_000998
Spectrum4_001126
Spectrum5_001466
Spectrum_001713
UNII-JMS50MPO89
[2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
losartan
losartan potassium
15
Clopidogrelapproved, nutraceuticalPhase 4778120202-66-6, 113665-84-260606
Synonyms:
( )-(S)-Clopidogrel
(+)-(S)-Clopidogrel
(+)-Clopidogrel
(S)-Clopidogrel
(S)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate
113665-84-2
AC-19024
AC1L1TKZ
AC1Q41I9
BIDD:GT0284
BRD-K27721098-065-02-9
BSPBio_003211
C16H16ClNO2S
CGE
CHEBI:37941
CHEMBL1771
CID60606
CLOPIDOGREL SULFATE
CPD000550475
Clopidogrel
Clopidogrel (INN)
Clopidogrel (TN)
Clopidogrel [BAN:INN]
Clopidogrel [Ban:Inn]
Clopidogrel [INN:BAN]
Clopidogrel bisulfate
Clopidogrel bisulphate
Clopidogrel sulfate
Clopidogrelum
D07729
DB00758
DivK1c_000787
HMS2090O21
HMS502H09
HSDB 7430
IDI1_000787
 
Isocover
KBio1_000787
KBio2_000545
KBio2_003113
KBio2_005681
KBio3_002431
KBioGR_000689
KBioSS_000545
LS-172232
MLS001165708
MLS001195633
MLS001304711
Methyl (+)-(S)-alpha-(o-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4H)-acetate
MolPort-002-885-817
MolPort-003-845-991
NCGC00163329-02
NINDS_000787
Plavix
Plavix (TN)
SAM002589956
SMR000550475
SPBio_000463
SR 25990
STK580572
STOCK5S-27782
Spectrum2_000512
Spectrum3_001606
Spectrum4_000175
Spectrum_000105
TL8000400
UNII-A74586SNO7
Zyllt
clopidogrel
clopidogrel, (+)(S)-isomer
methyl (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoate
methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate
nchem.651-comp8
16Anti-Infective AgentsPhase 4, Phase 1, Phase 222062
17Adrenergic beta-AntagonistsPhase 4, Phase 11193
18Lipid Regulating AgentsPhase 42766
19Adrenergic AntagonistsPhase 4, Phase 11573
20Immunosuppressive AgentsPhase 4, Phase 3, Phase 1, Phase 213086
21Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 123689
22Adrenergic alpha-AntagonistsPhase 4739
23Adrenergic alpha-1 Receptor AntagonistsPhase 4480
24Anticholesteremic AgentsPhase 42025
25Vasodilator AgentsPhase 4, Phase 3, Phase 13543
26Hydroxymethylglutaryl-CoA Reductase InhibitorsPhase 41998
27HIV Protease InhibitorsPhase 45470
28
protease inhibitorsPhase 45471
Synonyms:
 
protease inhibitors
29Hypolipidemic AgentsPhase 42785
30Anti-Inflammatory AgentsPhase 4, Phase 3, Phase 110729
31Neurotransmitter AgentsPhase 4, Phase 118340
32Adrenergic AgentsPhase 4, Phase 15352
33AntimetabolitesPhase 4, Phase 1, Phase 212054
34Antihypertensive AgentsPhase 44207
35AntipyreticsPhase 41605
36Anti-Inflammatory Agents, Non-SteroidalPhase 4, Phase 3, Phase 14443
37Psychotropic DrugsPhase 4, Phase 36430
38Tranquilizing AgentsPhase 4, Phase 34265
39AnticonvulsantsPhase 4, Phase 32695
40Anti-Anxiety AgentsPhase 4, Phase 31885
41Cyclooxygenase InhibitorsPhase 42870
42Antirheumatic AgentsPhase 4, Phase 3, Phase 1, Phase 210956
43Central Nervous System DepressantsPhase 4, Phase 313403
44AngiotensinogenPhase 41177
45calcium channel blockersPhase 4, Phase 31985
46diureticsPhase 41418
47Cytochrome P-450 Enzyme InhibitorsPhase 43917
48Angiotensin-Converting Enzyme InhibitorsPhase 4724
49Angiotensin Receptor AntagonistsPhase 41191
50
Angiotensin IIPhase 4117868521-88-0, 11128-99-765143, 172198
Synonyms:
1-8-Angiotensin I
1-L-Aspasaginyl-5-L-valyl angiotensin octapeptide
Ang II
Angiotensin 2
Angiotensin II (human)
 
Angiotensin II (mouse)
Angiotonin
Asp-arg-val-TYR-ile-his-pro-phe
Human angiotensin II
Hypertensin
Ile(5)-angiotensin II

Interventional clinical trials:

(show top 50)    (show all 56)
idNameStatusNCT IDPhase
1The Preventive Efficacy of Carvedilol on Cardiac Dysfunction in Duchenne Muscular DystrophyUnknown statusNCT00606775Phase 4
2Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular DiseaseCompletedNCT00190580Phase 4
3Clopidogrel High Dose Evaluation for the Patient With Coronary Artery Disease in JapanCompletedNCT01069302Phase 4
4Evaluation of Routine Follow-up Coronary Angiography After Percutaneous Coronary Intervention TrialCompletedNCT01123291Phase 4
5Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting Stent TrialCompletedNCT01035450Phase 4
6Short and Optimal Duration of Dual Antiplatelet Therapy StudyCompletedNCT01659034Phase 4
7NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-eluting Stent TrialCompletedNCT01303640Phase 4
8Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS)CompletedNCT00242944Phase 4
9Effect of Passive Exercise on Systemic Endothelial Function in Elderly Patients With Chronic Heart FailureCompletedNCT00733161Phase 4
10The Study on Profile and Genetic Factors of Aspirin Resistance (ProGEAR Study)CompletedNCT00250380Phase 4
11Carvedilol Post-intervention Long-term Administration in Large-scale TrialCompletedNCT01155635Phase 4
12PROs in Chronic Low Back Pain Patients With Accompanying Lower Limb Pain (Neuropathic Component) Treated With PregabalinCompletedNCT02273908Phase 4
13ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 StudyRecruitingNCT02619760Phase 4
14Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and Coronary stEnt (OAC-ALONE) StudyRecruitingNCT01962545Phase 4
15Anti-inflammatory Effects of Rivaroxaban Versus DabigatranRecruitingNCT02331602Phase 4
16The Preventive Implantation of Bioresorbable Vascular Scaffold on Functionally Insignificant Stenosis With Vulnerable Plaque CharacteristicsRecruitingNCT02316886Phase 4
17Effect of Intensive Blood Pressure Control on Progression of Coronary Atherosclerosis: Randomized Evaluation by Intravascular UltrasoundTerminatedNCT01230216Phase 4
18Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and AntioxidantsCompletedNCT00419146Phase 2, Phase 3
19A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)CompletedNCT00912093Phase 3
20An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic PainCompletedNCT01202227Phase 3
21Aromatase Inhibitors or GnRH-a for Uterine AdenomyosisCompletedNCT01218581Phase 2, Phase 3
22A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular EdemaCompletedNCT01100307Phase 3
23PhaseⅢOpen-label Study of MRA for Rheumatoid Arthritis(RA)CompletedNCT00380601Phase 3
24Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA220JP or MRA221JPCompletedNCT00144586Phase 3
25A Phase3 Study to Evaluate the Efficacy and Safety of MEDI3250 in Healthy Japanese Children Age 7 Years Through 18 YearsCompletedNCT02269475Phase 3
26Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular DegenerationActive, not recruitingNCT02462486Phase 3
27Study of Cetuximab With Concomitant-boost Radiotherapy in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)CompletedNCT00865098Phase 2
28Low Intensity Physical Activity Leads to Improvement in Brachial-ankle Pulse Wave Velocity of HemiplegicsCompletedNCT01569386Phase 2
29Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)CompletedNCT00655785Phase 1, Phase 2
30Neoadjuvant Nab-PTX and Trastuzumab for ER Negative and HER2 Positive Breast CancerRecruitingNCT02598310Phase 2
31Ponatinib in Patients With Resistant Chronic Phase Chronic Myeloid Leukemia (CML) to Characterize the Efficacy and Safety of a Range of DosesRecruitingNCT02467270Phase 2
32Study of TBI-1501 for Relapsed or Refractory Acute Lymphoblastic LeukemiaNot yet recruitingNCT03155191Phase 1, Phase 2
33Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic CancerUnknown statusNCT00639925Phase 1
34Antiangiogenic Peptide Vaccine Therapy in Treating Patient With Hepatocellular CarcinomaUnknown statusNCT01266707Phase 1
35Open-label, Single-arm Study to Assess the Pharmacokinetics, Safety, and Tolerability of a Single Subcutaneous Dose of Icatibant in Healthy Japanese VolunteersCompletedNCT02045264Phase 1
36An Open Label, Single Arm, Dose Escalation Phase 1 Trial of PRI-724 in Patients With HCV-induced CirrhosisRecruitingNCT02195440Phase 1
37Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy With Pitavastatin in Coronary Artery Disease (REAL-CAD)Unknown statusNCT01042730
38Comparison of Novo Rapid 30 Mix Injection FlexPen® and Humalog 25 Mix Injection KwikPen® in Type 2 Diabetic PatientsUnknown statusNCT00806975
39Study of Aprepitant / Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV) in Colorectal Cancer Patients - SENRI TrialUnknown statusNCT01344304
40The Cardiac Insufficiency BIsoprolol Study in Japanese Patients With Chronic Heart Failure (CIBIS-J)Unknown statusNCT02137733
41Epithelioid Hemangioma of Bone And Soft TissueCompletedNCT03169595
42A Study of Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With MRA(a Development Code of Tocilizumab, an Anti IL-6 Receptor Monoclonal Antibody.)CompletedNCT00661284
43Retina Projection System Trials for Low Vision PeopleCompletedNCT00219427
44The Effect of Adaptive Servo Ventilation and Oxygen Therapy in Central Sleep Apnea PatientsCompletedNCT01187823
45Observational Study of Pediatric Rheumatic Diseases: The CARRA RegistryRecruitingNCT02418442
46Start Time Optimization of Biologics in Polyarticular JIARecruitingNCT02593006
47Kyoto Congestive Heart Failure StudyRecruitingNCT02334891
48A Follow-up Evaluation Study of PRI-724-1101RecruitingNCT02828254
49Gastric Cancer Screening Quality Improvement System EstablishmentRecruitingNCT02457624
50Japanese Idiopathic Interstitial Pneumonias RegistryRecruitingNCT03041623

Search NIH Clinical Center for Kimura Disease

Genetic Tests for Kimura Disease

About this section

Anatomical Context for Kimura Disease

About this section

MalaCards organs/tissues related to Kimura Disease:

36
Skin, Lymph node, Bone, Salivary gland, Breast, Colon, Brain

Publications for Kimura Disease

About this section

Articles related to Kimura Disease:

(show top 50)    (show all 94)
idTitleAuthorsYear
1
Kimura disease. No age or ethnicity limit. (26905356)
2016
2
Concurrent Kimura disease and lupus nephritis: A case report. (27741124)
2016
3
Kimura Disease Presenting as Forehead Soft Mass. (27100647)
2016
4
Comparison of Local Recurrence Rate of Three Treatment Modalities for Kimura Disease. (26674917)
2016
5
Human Polyomavirus-6 Infecting Lymph Nodes of a Patient With an Angiolymphoid Hyperplasia With Eosinophilia or Kimura Disease. (26962076)
2016
6
An Unusual Clinical Presentation of Kimura Disease Manifesting with a Typical Cephalocervical Lesion and an Atypical Subcutaneous Hip Mass Lesion. (27086824)
2016
7
Kimura disease in a Maori man with nephrotic syndrome. (27981775)
2016
8
Kimura Disease of the Breast - A Previously Undescribed Entity. (27058987)
2016
9
Kimura disease as mimicker of lymphoma - A case report. (27728556)
2016
10
A case of refractory Kimura disease with a buccal bulky mass successfullyA treated with low-dose cyclosporine A: Report andA reviewA ofA the literature. (26666475)
2016
11
Eosinophilia and multiple lymphadenopathy: Kimura disease, a rare, but benign condition. (27581232)
2016
12
A mass under parotid gland: a patient with kimura disease. (25668110)
2015
13
Retrospective Multicentric Study of 25 Kimura Disease Patients: Emphasis on Therapeutics and Shared Features with Cutaneous IgG4-Related Disease. (26452023)
2015
14
Recurrent Kimura Disease of the Inner Canthus With No Lymphadenopathy. (26020715)
2015
15
Kimura disease associated with severe visual dysfunction due to remarkable periorbital involvement. (26031497)
2015
16
Pulmonary embolism as the initial clinical presentation of Kimura disease: case report and literature review. (25699606)
2015
17
Kimura disease accompanied with nephrotic syndrome in a 45-year-old male. (25928198)
2015
18
Kimura disease: A rare case of bilateral infra-auricular masses. (26831431)
2015
19
Paradoxical brain embolism associated with Kimura disease mimics watershed infarction. (25447210)
2015
20
Kimura Disease Presenting As an Eyelid Mass in a Young Asian Male. (26080258)
2015
21
Kimura Disease Mimicking an Aneurysm of the Radial Artery. (26362092)
2015
22
Unusual Cause of Swelling in the Upper Limb: Kimura Disease. (26421119)
2015
23
Preliminary study of diffusion-weighted imaging and magnetic resonance spectroscopy imaging in kimura disease. (25377973)
2014
24
Kimura disease complicated with bowel infarction and multiple arterial thromboses in the extremities. (24356478)
2014
25
Kimura disease manifesting as synchronous bilateral parotid swelling in a young middle-eastern patient. (25544928)
2014
26
Kimura Disease Simulating Hodgkin's Lymphoma on (18)F FDG PET-CT: Report of a Case. (26396638)
2014
27
Kimura disease associated with IgA nephropathy. (24656163)
2014
28
Kimura Disease: rare cause of a slowly progressive orbital mass. (24119195)
2013
29
Intraparotid Kimura disease. (23021002)
2013
30
Kimura Disease of the Epiglottis: A Case Report and Review of Literature. (23907346)
2013
31
The false-positive finding of left pulmonary Kimura disease on 18F-FDG PET/CT. (23510880)
2013
32
Kimura disease involving a caruncle. (23543681)
2013
33
Elevated numbers of cells producing interleukin-5 and interleukin-10 in a boy with Kimura disease. (22627370)
2012
34
Kimura disease: CT and MR imaging findings. (22173767)
2012
35
Kimura disease: diagnostic challenges and clinical management. (21763034)
2012
36
Treatment of Kimura disease with photodynamic therapy: a case study. (22369733)
2012
37
Epitrochlear mass in a patient on maintenance hemodialysis--Kimura disease. (22280213)
2012
38
Kimura disease: a case report and review of the literature with a new management protocol. (21423602)
2011
39
Treatment of Kimura disease with intravenous immunoglobulin. (22106083)
2011
40
Microfilaria in lymph node mimicking Kimura disease. (23508372)
2011
41
Head and neck MRI of Kimura disease. (21849365)
2011
42
Kimura disease in children: a case report and a summary of the literature in Chinese. (21436734)
2011
43
Kimura disease in the parotid gland. (21239930)
2011
44
Kimura disease with necrosis of the limbs and mononeuritis multiplex. (21418278)
2011
45
Juvenile temporal arteritis with perifollicular lymphoid proliferation resembling Kimura disease. Report of a case. (21182505)
2011
46
Thrombotic storm in Kimura disease. (19468829)
2010
47
Renal epitelial neoplasia associated with Kimura disease. (20876951)
2010
48
Kimura disease: An unusual cause of head and neck masses. Report of 2 cases. (20155679)
2010
49
Kimura disease: a case report and review of the Chinese literature. (19052471)
2009
50
Kimura disease of the eyelid in an Indian man. (19594570)
2009

Variations for Kimura Disease

About this section

Expression for genes affiliated with Kimura Disease

About this section
Search GEO for disease gene expression data for Kimura Disease.

Pathways for genes affiliated with Kimura Disease

About this section

Pathways related to Kimura Disease according to GeneCards Suite gene sharing:

(show all 21)
idSuper pathwaysScoreTop Affiliating Genes
19.7IL4, IL5
29.7IL4, IL5
39.7IL4, IL5
49.7IL4, IL5
59.5CCL5, IL4
69.2CCL11, IL4, IL5
7
Show member pathways
9.2CCL11, IL4, IL5
89.1CCR3, IL4, IL5
9
Show member pathways
8.9CCL11, IL4, IL5, RNASE3
10
Show member pathways
8.9CCL11, CCL5, CCR3
11
Show member pathways
8.9CCL11, CCL5, CCR3
12
Show member pathways
8.9IL4, IL5, TSLP
138.7CCL11, CCL5, IL4, IL5
148.7CCL11, IL33, IL4, IL5
158.3IL33, IL4, IL5, TSLP
168.3IL33, IL4, IL5, TSLP
17
Show member pathways
8.2CCL11, CCL5, IL33, IL4, IL5
18
Show member pathways
8.1CCL11, CCL5, CCR3, IL4, IL5
198.1CCL11, CCL5, CCR3, IL4, IL5
20
Show member pathways
8.1CCL11, CCL5, CCR3, IL4, IL5
21
Show member pathways
7.3CCL11, CCL5, CCR3, IL4, IL5, TSLP

GO Terms for genes affiliated with Kimura Disease

About this section

Cellular components related to Kimura Disease according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular regionGO:00055767.7CCL11, CCL5, IL33, IL4, IL5, RNASE3
2extracellular spaceGO:00056157.0CCL11, CCL5, IL33, IL4, IL5, RNASE3

Biological processes related to Kimura Disease according to GeneCards Suite gene sharing:

(show all 17)
idNameGO IDScoreTop Affiliating Genes
1innate immune response in mucosaGO:000222710.3IL4, RNASE3
2positive regulation of B cell proliferationGO:003089010.3IL4, IL5
3cellular response to interferon-gammaGO:007134610.2CCL11, CCL5
4eosinophil chemotaxisGO:004824510.2CCL11, CCL5
5cellular defense responseGO:000696810.2CCR3, IL4
6positive regulation of immunoglobulin secretionGO:005102410.2IL33, IL5
7positive regulation of JAK-STAT cascadeGO:004642710.2CCL5, IL5
8positive regulation of interleukin-13 productionGO:003273610.1IL33, IL4
9monocyte chemotaxisGO:000254810.1CCL11, CCL5
10positive regulation of T cell proliferationGO:004210210.1CCL5, IL4
11positive regulation of tyrosine phosphorylation of STAT proteinGO:004253110.0CCL5, IL4
12response to cytokineGO:00340979.7CCL5, IL4
13chemokine-mediated signaling pathwayGO:00700989.6CCL11, CCL5, CCR3
14type 2 immune responseGO:00420929.5IL33, IL4
15immune responseGO:00069559.4CCL11, CCL5, IL4, IL5
16chemotaxisGO:00069359.2CCL11, CCL5, CCR3, IL4
17inflammatory responseGO:00069549.1CCL11, CCL5, CCR3, IL5

Molecular functions related to Kimura Disease according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1chemokine activityGO:000800910.1CCL11, CCL5
2cytokine activityGO:00051257.4CCL11, CCL5, IL33, IL4, IL5, TSLP

Sources for Kimura Disease

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet